Stake Purchase • Life Science

Polaris Partners Invests In Cyclerion

On June 4, 2021, growth capital firm Polaris Partners invested in life science company Cyclerion

Investment Context

This is Polaris Partners’ 28th transaction in the Life Science sector.
This is Polaris Partners’ 66th transaction in the United States.
This is Polaris Partners’ 22nd transaction in Massachusetts.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free

Investment Summary
Date	June 4, 2021
Target	Cyclerion
Sector	Life Science
Investor(s)	Polaris Partners
Deal Type	Stake Purchase

Target Company

Cyclerion

Cambridge, Massachusetts, United States

Cyclerion is an independent company working at the forefront of CNS drug development. Cyclerion mission is to develop innovative medicines that improve brain function for patients in desperate need of new treatment options. Cyclerion was founded in 2018 and is based in Cambridge, Massachusetts.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Polaris Partners

Investor Investor

Category	Growth Capital Firm
Founded	1996
PE ASSETS	5.0B USD
Size	Large
Type	Sector Agnostic

DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.

Deal Context for Investor	#
Overall	73 of 86
Sector: Life Science	28 of 39
Type: Stake Purchase	3 of 3
State: Massachusetts	22 of 27
Country: United States	66 of 77
Year: 2021	9 of 15

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-05-27	August Bioservices Nashville, Tennessee, United States August Bioservices is a quality-driven CDMO that offers end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish CGMP manufacturing to clients of all sizes and stages, from pre-clinical to commercial, all under one roof. August Bioservices was founded in 2017 and is based in Nashville, Tennessee.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-05-27

August Bioservices

Nashville, Tennessee, United States

August Bioservices is a quality-driven CDMO that offers end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish CGMP manufacturing to clients of all sizes and stages, from pre-clinical to commercial, all under one roof. August Bioservices was founded in 2017 and is based in Nashville, Tennessee.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-06-08	Faro Health San Diego, California, United States Faro Health is building a suite of integrated cloud-based tools for clinical trial management aimed at improving the cost, speed, and efficacy of trials. Faro Health was founded in 2019 and is based in San Diego, California.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-06-08

Faro Health

San Diego, California, United States

Faro Health is building a suite of integrated cloud-based tools for clinical trial management aimed at improving the cost, speed, and efficacy of trials. Faro Health was founded in 2019 and is based in San Diego, California.

Buy

Explore Related M&A Activity

Life Science M&A - Stake Purchase M&A Deals - Massachusetts M&A - United States M&A - 2021 M&A